These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 30592286)
1. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2. Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway. Yang S; Li X; Shen W; Hu H; Li C; Han G J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055 [TBL] [Abstract][Full Text] [Related]
3. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition. Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2. Li J; Yuan J; Yuan X; Zhao J; Zhang Z; Weng L; Liu J Int J Oncol; 2016 Feb; 48(2):541-50. PubMed ID: 26648487 [TBL] [Abstract][Full Text] [Related]
5. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2. Jiang G; Wen L; Deng W; Jian Z; Zheng H Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
7. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G; Lin Y; Zhang H; Wu D Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123 [TBL] [Abstract][Full Text] [Related]
8. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer. Ji H; Sang M; Liu F; Ai N; Geng C Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621 [TBL] [Abstract][Full Text] [Related]
9. LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity. Yao H; Hou G; Wang QY; Xu WB; Zhao HQ; Xu YC Int J Oncol; 2020 Jan; 56(1):85-100. PubMed ID: 31746422 [TBL] [Abstract][Full Text] [Related]
10. Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression. Wang P; Liu X; Han G; Dai S; Ni Q; Xiao S; Huang J Cell Cycle; 2019 Sep; 18(18):2359-2376. PubMed ID: 31387451 [No Abstract] [Full Text] [Related]
11. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma. Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1. Zhang L; Zhang T; Deng Z; Sun L Oncol Rep; 2019 Mar; 41(3):1669-1677. PubMed ID: 30664185 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression. Chen DL; Lu YX; Zhang JX; Wei XL; Wang F; Zeng ZL; Pan ZZ; Yuan YF; Wang FH; Pelicano H; Chiao PJ; Huang P; Xie D; Li YH; Ju HQ; Xu RH Theranostics; 2017; 7(19):4836-4849. PubMed ID: 29187907 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2. He J; Wang J; Li S; Li T; Chen K; Zhang S Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486 [TBL] [Abstract][Full Text] [Related]
15. Zinc finger E‑box binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma. Li Q; Ma L; Wu Z; Wang G; Huang Q; Shen Z; Yu R Mol Med Rep; 2019 Jun; 19(6):4545-4552. PubMed ID: 30957184 [TBL] [Abstract][Full Text] [Related]
16. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2. Zhu W; Luo X; Fu H; Liu L; Sun P; Wang Z Pathol Res Pract; 2019 Oct; 215(10):152577. PubMed ID: 31405759 [TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of Zheng WJ; Yao M; Fang M; Wang L; Dong ZZ; Yao DF World J Gastroenterol; 2018 Aug; 24(32):3650-3662. PubMed ID: 30166860 [TBL] [Abstract][Full Text] [Related]
18. MiR-138-5p suppresses lung adenocarcinoma cell epithelial-mesenchymal transition, proliferation and metastasis by targeting ZEB2. Zhu D; Gu L; Li Z; Jin W; Lu Q; Ren T Pathol Res Pract; 2019 May; 215(5):861-872. PubMed ID: 30712885 [TBL] [Abstract][Full Text] [Related]
19. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors. Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340 [TBL] [Abstract][Full Text] [Related]
20. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Jin Y; Wang J; Han J; Luo D; Sun Z Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]